JMP Securities analyst Patrick Walravens maintained a Buy rating on Similarweb (SMWB – Research Report) today and set a price target of ...

JMP Securities raised the firm’s price target on Similarweb (SMWB) to $17 from $16 and keeps an Outperform rating on the shares. The ...

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

JMP Securities raised the firm’s price target on Atlanticus (ATLC) to $54 from $45 and keeps an Outperform rating on the ...

JMP Securities lowered the firm’s price target on Angi Inc. (ANGI) to $3 from $3.25 and keeps an Outperform rating on the ...

Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market ...

On Wednesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.66 which represents a decrease of $-0.18 or -6.34% from the prior close of $2.84. The stock opened at $2.88 and ...

On Wednesday, Savara Inc (SVRA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.58 or -15.14% from the prior close of $3.83. The stock opened at $3.67 and touched a low ...

Ibotta posted third-quarter adjusted earnings of 94 cents per share, which may not compare to market estimates of 35 cents ...

Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...

JMP Securities analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $27 from $43 and keeps a Market Perform rating on the shares following Q3 results.